Research Report
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2014; 20(15): 4382-4392
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4382
Figure 1
Figure 1 Flow chart of trial participants. 1Excluded from analysis due to > 3 kg weight change. RT: Resistance training; NAFLD: Non alcoholic liver disease.
Figure 2
Figure 2 Change (absolute) in hepatorenal-ultrasound index values between baseline and end of trial by treatment arm. A: Resistance arm; B: Stretching arm. Each line represents a single patient. HRI: Hepatorenal-ultrasound index.
Figure 3
Figure 3 Change (absolute) in body composition parameters between baseline and end of trial by treatment arm. P represents the significance of difference between resistance and stretching arm for each parameter (n = 55). LBM: Lean body mass.